SBI Securities’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Sell
22,094
-536
-2% -$30.8K 0.03% 250
2026
Q1
$1.37M Sell
22,630
-506
-2% -$29.5K 0.04% 227
2025
Q4
$1.25M Buy
23,136
+1,488
+7% +$71.6K 0.03% 244
2025
Q3
$976K Buy
21,648
+560
+3% +$26.2K 0.03% 278
2025
Q2
$976K Buy
21,088
+152
+0.7% +$7.46K 0.03% 269
2025
Q1
$1.28M Sell
20,936
-21
-0.1% -$1.22K 0.04% 220
2024
Q4
$1.19M Buy
+20,957
New +$1.17M 0.04% 233

Other funds holding BMY

SBI Securities's BMY Position: Q2 2026 in Review

SBI Securities reduced its Bristol-Myers Squibb (BMY) stake by 2.4% in Q2 2026, selling an estimated $30.8K and leaving 22,094 shares worth $1.27M. The position accounts for 0.03% of the portfolio, ranked #250.

SBI Securities first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.37M in Q1 2026. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • SBI Securities held 22,094 shares of Bristol-Myers Squibb worth $1.27M as of Q2 2026.
  • SBI Securities sold 536 Bristol-Myers Squibb shares in Q2 2026, an estimated $30.8K.
  • Bristol-Myers Squibb made up 0.03% of SBI Securities's portfolio in Q2 2026, its #250 holding.
  • SBI Securities first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Bristol-Myers Squibb position peaked at $1.37M in Q1 2026.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.